Evidence Central: Cochrane Abstracts: By_Topic-A-Adrenergic_beta-Agonists

Browse

|Home|Mobile|Archive|Login

Cochrane Abstracts

By Topic

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Adrenergic beta-Agonists

Addition of intravenous aminophylline to inhaled beta 2 -agonists in adults with acute asthma
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children
Addition of long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma
Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children
Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma
Betamimetics for inhibiting preterm labour
Betamimetics for suspected impaired fetal growth
Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus long-acting beta 2 -agonists for chronic obstructive pulmonary disease
Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease
Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children
Continuous versus intermittent beta-agonists for acute asthma
Drug treatment for facioscapulohumeral muscular dystrophy
Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma
Inhaled beta2-agonists for asthma in mechanically ventilated patients
Inhaled beta2-agonists for non-specific chronic cough in children
Inhaled bronchodilators for cystic fibrosis
Inhaled magnesium sulfate in the treatment of acute asthma
Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment
Intravenous beta2-agonists for acute asthma in the emergency department
Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease
Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease
Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children
Long-acting beta2-agonists for bronchiectasis
Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid
Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma
Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction
Nebulized epinephrine for croup in children
Oral betamimetics for maintenance therapy after threatened preterm labour
Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma
Prophylactic oral betamimetics for preventing preterm labour in singleton pregnancies
Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events
Regular treatment with formoterol for chronic asthma: serious adverse events
Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events
Short acting beta2-agonists for bronchiectasis
Short acting beta2-agonists for recurrent wheeze in children under two years of age
Short-acting beta2-agonists for stable chronic obstructive pulmonary disease
The effect of adding inhaled corticosteroids to tiotropium and long-acting beta 2 -agonists for chronic obstructive pulmonary disease